Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world

International Journal of Cardiology

Volumn 155, Issue 3, 2012, Pages 424-429

  Ruff, Christian T ^a   Giugliano, Robert P ^a   Antman, Elliott M ^a   Murphy, Sabina A ^a   Lotan, Chaim ^b   Heuer, Herbertus ^c   Merkely, Bela ^d   Baracioli, Luciano ^e   Schersten, Fredrik ^f   Seabro Gomes, Ricardo ^g   Braunwald, Eugene ^a   Wiviott, Stephen D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c ST JOHANNES HOSPITAL   (Germany)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f HELSINGBORG HOSPITAL   (Sweden)

^g Instituto do Coracao   (Portugal)

Author keywords

Clopidogrel; HDI; Prasugrel; Regional differences; TRITON TIMI 38

Indexed keywords

CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; PRASUGREL;

ACUTE CORONARY SYNDROME; ADJUVANT THERAPY; ADULT; AFRICA; ARTICLE; ASIA; BLEEDING; BLOOD CLOT LYSIS; CAUSE OF DEATH; COMORBIDITY; CONTROLLED STUDY; CORONARY STENT; DEATH; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; EASTERN EUROPE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE EAST; NORTH AMERICA; PRIORITY JOURNAL; RATING SCALE; SENSITIVITY ANALYSIS; SOUTH AMERICA; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; TREATMENT OUTCOME; TREND STUDY; WESTERN EUROPE;

ACUTE CORONARY SYNDROME; CAUSE OF DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PIPERAZINES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RETROSPECTIVE STUDIES; THIOPHENES; TICLOPIDINE; TREATMENT OUTCOME; WORLD HEALTH;

EID: 84857789982     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.040     Document Type: Article

References (40)

1. World Health Organization The World Health Report 2000 health systems: improving performance 2000 WHO Geneva 21 46
2. P. Moise, S. Jacobzone and the ARD-IHD Experts Group Outcomes of interventions for IHD. OECD Study of cross-national differences in the treatment, costs and outcomes of ischaemic heart disease 2003 OECD Paris 70 79
3. W.C. Chang, W.K. Midodzi, and C.M. Westerhout Are international differences in the outcomes of acute coronary syndromes apparent or real? A multilevel analysis J Epidemiol Community Health 59 2005 427 433 (Pubitemid 40559207)
4. M. Gupta, W.C. Chang, and F. Van de Werf International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2 Eur Heart J 24 2003 1640 1650 (Pubitemid 37174903)
5. R.P. Giugliano, J. Llevadot, and R.G. Wilcox Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II Eur Heart J 22 2001 1702 1715 (Pubitemid 32896370)
6. K.P. Alexander, E.D. Peterson, and C.B. Granger Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb. Global use of strategies to open occluded arteries in acute coronary syndromes trial J Am Coll Cardiol 32 1998 2023 2030 (Pubitemid 29010471)
7. G.I. Barbash, M. Modan, U. Goldbourt, H.D. White, and F. Van de Werf Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: variation by country beyond predictive profile. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial J Am Coll Cardiol 21 1993 281 286 (Pubitemid 23047906)
8. M.G. Cohen, C.M. Pacchiana, and R. Corbalan Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial Am Heart J 141 2001 391 401 (Pubitemid 32200267)
9. K.A. Fox, S. Goodman, F. Bigonzi, V. Le Louer, and M. Cohen Inter-regional differences and outcome in unstable angina; analysis of the international ESSENCE trial. Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events Eur Heart J 21 2000 1433 1439 (Pubitemid 30636322)
10. Y. Fu, W.C. Chang, and D. Mark Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation. Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) II Investigators Circulation 102 2000 1375 1381
11. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
12. J.C. O'Shea, and R.M. Califf International differences in treatment effects in cardiovascular clinical trials Am Heart J 141 2001 875 880 (Pubitemid 32378503)
13. J.C. O'Shea, and R.M. Califf International differences in cardiovascular clinical trials Am Heart J 141 2001 866 874 (Pubitemid 32378502)
14. J.C. O'Shea, and R.M. Calif Inter-regional differences in acute coronary syndrome trials Eur Heart J 21 2000 1397 1399 (Pubitemid 30636317)
15. E.M. Antman, M. Hand, and P.W. Armstrong 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration with the Canadian Cardiovascular Society Endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee Circulation 117 2008 296 329
16. S.B. King III, S.C. Smith Jr. , and J.W. Hirshfeld Jr. 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee Circulation 117 2008 261 295
17. F. Van de Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
18. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 2007 e1 e157
19. Task Force for Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology, J.P. Bassand, and C.W. Hamm Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
20. S. Silber, P. Albertsson, and F.F. Aviles Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology Eur Heart J 26 2005 804 847
21. J.P. Bassand, C.W. Hamm, and D. Ardissino Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
22. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
23. "History of the Human Development Report". United Nations Development Programme. http:hdr.undp.org/en/humandev/reports/. Retrieved 05 February 2010.
24. "Human development indices". United Nations Development Programme. http:hdr.undp.org/en/media/HDR-2009-EN-Complete.pdf. Retrieved 05 February 2010.
25. S.D. Wiviott, E.M. Antman, and C.M. Gibson Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) Am Heart J 152 2006 627 635 (Pubitemid 44396884)
26. L. Mauri, W.H. Hsieh, J.M. Massaro, K.K. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029 (Pubitemid 46376802)
27. S.D. Wiviott, E. Braunwald, and D.J. Angiolillo Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38 Circulation 118 2008 1626 1636
28. S.W. Glickman, J.G. McHutchison, and E.D. Peterson Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 2009 816 823
29. A. Budaj, D. Brieger, and P.G. Steg Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE) Am Heart J 146 2003 999 1006 (Pubitemid 37500773)
30. Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression using Integrilin Therapy N Engl J Med 339 1998 436 443
31. The GUSTO Investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
32. F. Van de Werf, E.J. Topol, and K.L. Lee Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries JAMA 273 1995 1586 1591
33. R.P. Giugliano, J. Llevadot, and R.G. Wilcox Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II Eur Heart J 22 2001 1702 1715 (Pubitemid 32896370)
34. M. Cohen, C. Demers, and E.P. Gurfinkel A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group N Engl J Med 337 1997 447 452 (Pubitemid 27333045)
35. J.L. Mega, S.L. Close, and S.D. Wiviott Cytochrome P-450 polymorphisms and response to clopidogrel N Engl J Med 360 2009 354 362
36. J.L. Mega, S.L. Close, and S.D. Wiviott Cytochrome P450 genetic polymorphisms and the response to prasugrel relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes Circulation 119 2009 2553 2560
37. T. Simon, C. Verstuyft, and M. Mary-Krause Genetic determinants of response to clopidogrel and cardiovascular events N Engl J Med 360 2009 363 375
38. A.R. Shuldiner, J.R. O'Connell, and K.P. Bliden Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy JAMA 302 2009 849 857
39. E.P. Gurfinkel, G. Bozovich, and B. Mautner International comparison of mortality rates in patients with non-ST elevation acute coronary events Heart 89 2003 1083 1084 (Pubitemid 37046854)
40. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150